Edition:
United Kingdom

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.50USD
22 Jan 2018
Change (% chg)

$0.05 (+2.04%)
Prev Close
$2.45
Open
$2.50
Day's High
$2.50
Day's Low
$2.50
Volume
3,799
Avg. Vol
14,355
52-wk High
$2.85
52-wk Low
$1.15

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: --
Market Cap(Mil.): $46.69
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​

* Proteon Therapeutics announces third quarter 2017 financial results

07 Nov 2017

BRIEF-Proteon Therapeutics Q2 loss $0.33 per share

* Proteon Therapeutics announces second quarter 2017 financial results

07 Aug 2017

BRIEF-Proteon Therapeutics files for shelf offering of up to 22.1 million shares

* Proteon Therapeutics Inc files for shelf offering of up to 22.1 million shares of common stock by selling stockholders‍​ - sec filing Source text - http://bit.ly/2wpHLJ0 Further company coverage:

03 Aug 2017

Earnings vs. Estimates